跳至主要内容
临床试验/NCT02681341
NCT02681341已完成不适用

Vascular Post Market Review

Baylor Research Institute1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2016年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
10
试验地点
1
主要终点
6 Month Duplex US Report to Measure Material Quality

研究概览

简要总结

The primary objective of this study is to confirm that properties of CardioCel provide operative benefit to surgeons when compared to Dacron, CorMatrix, and all other bovine pericardium not treated with proprietary ADAPT engineering.

详细描述

ENDPOINTS

  1. OR experience: suturability, handling, hemostasis, compliance to recipient vessel, blood loss, OR time.
  2. In-hospital survival
  3. MAE (Stroke, MI, death)
  4. 1 Month duplex US scan
  5. 6 month duplex US scan

Secondary Efficacy Endpoints

  1. Less than 50% stenosis at 6 months (PSV <150 cm/s)

Safety Endpoint

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Scheduled for carotid endarterectomy (CEA) with patch arterioplasty
  • Expected lifespan of over 24 months
  • Age over 18 years

排除标准

  • Revision of previous CEA arterioplasty
  • Active infection
  • Cerebral ischemic event (completed stroke) within 30 days of planned surgery
  • Pregnant or breastfeeding
  • Concomitant surgical or endovascular procedure being performed

结局指标

主要结局

6 Month Duplex US Report to Measure Material Quality

时间窗: Up to 6 months post CEA

The 6 month duplex US report will measure peak velocity and flow through the repaired carotid artery, caliber, and occlusion/lesion status as per normal parameters used in post-CEA scans.

次要结局

  • OR Data and Surgeon Feedback During the Procedure(procedure)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验